Home › Major Depressive Disorder › Washington
Pag-aaral pangklinika para sa Major Depressive Disorder sa Washington
20 pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa Washington.
Mga Lungsod sa Washington
Opisyal na teksto ng pag-aaral (English)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06559306A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06793397Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06830044A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07065240A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07610473A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07573176A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07300969Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06093906Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
- VA Portland Healthcare System, Vancouver
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 11, 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 23, 2025 · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Set 19, 2024 · NCT06005194Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.